pharmaphorum

APRIL 19, 2021

The UK’s unique offering as a life sciences research hub helped convince US biotech Novavax to develop its COVID-19 jab there, according to the head of the country’s Vaccines Taskforce. . Last August the UK government finalised a deal with Novavax to purchase 60 million doses of the NVX-CoV2373 vaccine, which will also be manufactured in the country at a plant owned by FUJIFILM Diosynth Biotechnologies in Stockton-on-Tees.

Vaccines 141

Vaccines 141

Outsourcing Pharma

APRIL 19, 2021

One Healthâs FidoCure is using genomics and AI technology to develop precision oncological treatments, and the work is benefiting human cancer research.

115

115

Pharma Times

APRIL 19, 2021

JCVI advises pregnant women in the UK be offered COVID-19 vaccination at the same time as the rest of the population

Vaccines 113

Vaccines 113

Drug Patent Watch

APRIL 17, 2021

This chart shows the pharmaceutical companies with the most powder dosed drugs. For a different perspective, see the most popular dosage types. The companies with the most powder dosed drugs…. The post Which pharmaceutical companies have the most powder dosed drugs? appeared first on DrugPatentWatch - Make Better Decisions.

Pharmaceutical Companies 95

Pharmaceutical Companies Pharmaceutical Companies Dosage 95

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Communication

pharmaphorum

APRIL 23, 2021

Two years ago the use of AI in pharma and healthcare looked to be quickly heading for what Gartner’s Hype Cycle model would term the Plateau of Productivity. After the COVID-powered digital transformations of both pharma and healthcare , there can be little doubt that artificial intelligence is already having a productive time across our sector. It could even be, as consultants GlobalData predicted back in January, this year’s most disruptive technology across the pharmaceutical industry, though

126

126

Pharma Marketing Network

APRIL 21, 2021

[link]. The Pharma Marketing Podcast is pleased to present this special guest episode from our friend and Editorial Advisory Board member Darshan Kulkarni, Sales and Marketing Oversight – April 21, 2021. Darshan Kulkarni and Marc Banjak, General Counsel at Dova Pharmaceuticals, discuss sales compliance in the life sciences. Sales and marketing representatives in the life science industry must comply with state and federal regulations.

90

90

Outsourcing Pharma

APRIL 20, 2021

Artelo Biosciences is investigating the viability of its novel cannabinoid product as a solution to treat cancer-related anorexia in oncology patients.

103

103

pharmaphorum

APRIL 20, 2021

Novartis has secured backing from NICE for its relapsing multiple sclerosis (RMS) therapy Kesimpta in the UK, just two weeks after the drug was approved by the national drugs regulator. . The cost-effectiveness agency has said that anti-CD20 antibody Kesimpta (ofatumumab) can be prescribed via the NHS in England and Wales as a treatment for adults with RMS with active disease, as either a first-line therapy or after alternative drugs have been tried.

Hospitals 111

Hospitals Documentation 111

Drug Patent Watch

APRIL 19, 2021

Annual Drug Patent Expirations for HETLIOZ Hetlioz is a drug marketed by Vanda Pharms Inc and is included in two NDAs. It is available from one supplier. There are fifteen…. The post New patent for Vanda Pharms drug HETLIOZ appeared first on DrugPatentWatch - Make Better Decisions.

88

88

Pharma Times

APRIL 20, 2021

Decision is based on results from the Phase II DESTINY-Breast01 trial

130

130

Advertisement

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

Outsourcing Pharma

APRIL 20, 2021

ImmunoScape plans to use the investor funds to grow its Asia presence, expand into the US, and to further develop its Deep Immunomics platform technology.

83

83

pharmaphorum

APRIL 19, 2021

French genomic medicines firm SparingVision has agreed to buy GAMUT Therapeutics, a biotech specialising in gene therapies for inherited eye diseases such as retinitis pigmentosa (RP) that could compete against Roche/Spark’s Luxturna in a wider patient group. . GAMUT’s lead product, now SPVN20, is a novel, mutation-agnostic gene therapy, which aims at restoring the function of dormant cone cells in the retina.

105

105

Drug Patent Watch

APRIL 19, 2021

Annual Drug Patent Expirations for IMBRUVICA Imbruvica is a drug marketed by Pharmacyclics Inc and is included in two NDAs. It is available from one supplier. There are thirty-nine patents…. The post New patent for Pharmacyclics Inc drug IMBRUVICA appeared first on DrugPatentWatch - Make Better Decisions.

82

82

Pharma Times

APRIL 23, 2021

Construction on Leiden, Netherlands site anticipated to begin later this year

123

123

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

NY Times

APRIL 22, 2021

A new study shows that a 20-year-old drug prevents scarring in mice. If it works on humans, it could change the lives of those with disfiguring wounds.

68

68

pharmaphorum

APRIL 23, 2021

Amarin’s Vazkepa cardiology drug has been backed by the UK’s drugs regulator, following approval in Europe at the end of March. . The Medicines and Healthcare products Regulatory Agency (MHRA) granted a marketing authorisation for Vazkepa (icosapent ethyl) as a treatment to reduce risk of cardiovascular events in high-risk patients. These are defined as patients who have elevated triglycerides and either established cardiovascular disease or diabetes and at least one additional cardiovascular ri

Diabetes 98

Diabetes 98

Drug Patent Watch

APRIL 19, 2021

This chart shows the pharmaceutical companies with the most patents in Denmark. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…. The post Which pharmaceutical companies have the most drug patents in Denmark? appeared first on DrugPatentWatch - Make Better Decisions.

Pharmaceutical Companies 66

Pharmaceutical Companies Pharmaceutical Companies 66

Pharma Times

APRIL 23, 2021

Drug demonstrated a 25% relative risk reduction in the first occurrence of major adverse cardiovascular events in REDUCE-IT trial

96

96

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Outsourcing Pharma

APRIL 19, 2021

A leader from digital health solutions firm CitiusTech suggests use of fast healthcare interoperability resources is useful in the face of evolving tech.

66

66

pharmaphorum

APRIL 21, 2021

The benefits of Johnson & Johnson’s COVID-19 vaccine outweigh a tiny risk of unusual blood clots forming, Europe’s drugs regulator has said. In a decision that will allow the rollout of vaccines in certain EU states, the European Medicines Agency’s safety committee said there appears to be a link to unusual blood clots combined with low blood platelets.

Vaccines 98

Vaccines 98

NY Times

APRIL 20, 2021

The European Union’s drug regulator said that the Johnson and Johnson vaccine should carry a warning of potential risk for rare blood clots on the label, but did not recommend stopping the vaccine, saying the benefits of the vaccine outweighed the risks.

Labelling 53

Labelling Vaccines Immunization Immunity 53

Pharma Times

APRIL 19, 2021

Five-year strategy will seek to transform key elements of organisation's approach to latest treatments

99

99

Advertisement

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

Drug Patent Watch

APRIL 22, 2021

Annual Drug Patent Expirations for PROCYSBI Procysbi is a drug marketed by Horizon Pharma Usa and is included in two NDAs. There are sixteen patents protecting this drug. Drug patent…. The post New patent for Horizon Pharma drug PROCYSBI appeared first on DrugPatentWatch - Make Better Decisions.

52

52

pharmaphorum

APRIL 22, 2021

Dr. Anne Kerber, VP, Head of Clinical Development, Europe at Kite, a Gilead Company, explains how the company works with researchers and physicians across Europe to expand patient access to cell therapy. This thought leadership series has been paid and developed by Kite, a Gilead Company. Cell therapy is a treatment involving the genetic modification and reprogramming of a patient’s immune cells to target their own specific cancer, making it a truly individualised medicine.

Immunity 98

Immunity Immunization Hospitals 98

Drug Channels

APRIL 23, 2021

Today’s guest post comes from Erica Conroy, Vice President of Specialty at CoverMyMeds. Erica discusses four technology areas that the healthcare network can embrace to increase speed to therapy, affordability, and adherence. To learn more about CoverMyMeds’ technology solutions, download their new whitepaper: Helping Patients Access Specialty Therapies: Autoimmune Conditions. ( Free download ).

52

52

Pharma Times

APRIL 20, 2021

Pharma and diagnostic sectors respond to organisation’s latest guideline recommendations

98

98

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

Drug Patent Watch

APRIL 23, 2021

This chart shows the pharmaceutical companies with the most patents in United Kingdom. Patents must be filed in each country (or, in some cases regional patent office) where patent protection…. The post Which pharmaceutical companies have the most drug patents in United Kingdom? appeared first on DrugPatentWatch - Make Better Decisions.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

pharmaphorum

APRIL 19, 2021

The EMA has started reviewing the emergency use application for GlaxoSmithKline and Vir Biotech’s COVID-19 antibody VIR-7831, which could become the fourth drug of its type cleared for early use in the EU. . The monoclonal antibody – also known as GSK4182136 – is being evaluated for the treatment of people with mild or moderate COVID-19 who are aged over 12 and don’t need oxygen supplementation, but are considered to be at risk of developing more severe symptoms.

Immunity 98

Immunity Immunization 98

Pharma Packaging Solutions

APRIL 21, 2021

Helping revolutionize the Packaging Industry, Carton Service is introducing a renewable line of packaging with their Cartons 4R Earth line. April 2021, Shelby, OH: Providing an alternative to the many plastic packaging options companies and consumers rely on, Carton Service CSi, LLC is a foods, liquid and medical packaging manufacturer offering a new line of renewable paper packaging for liquid, semi-solid or dry products called “Cartons 4R Earth”.

Packaging 52

Packaging 52

Pharma Times

APRIL 19, 2021

Ublituximab significantly reduced the annualised relapse rate in patients with relapsing forms of multiple sclerosis

80

80

Drug Patent Watch

APRIL 23, 2021

Annual Drug Patent Expirations for ZYDELIG Zydelig is a drug marketed by Gilead Sciences Inc and is included in one NDA. It is available from one supplier. There are thirteen…. The post New patent expiration for Gilead Sciences drug ZYDELIG appeared first on DrugPatentWatch - Make Better Decisions.

52

52